Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AVXL US Equity

Anavex Life Sciences Corp.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1314052 · FY ends Sep 30
$3.39
+0.19 (+5.94%)
USD · as of 2026-08-19 · marketstack
14 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-178-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-118-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-038-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-3113GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-07-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-208-K 8.01Other eventssec.gov ↗
2026-06-268-K 8.01Other eventssec.gov ↗
2026-05-228-K 8.01Other eventssec.gov ↗
2026-05-228-K 3.01Notice of delisting or failure to satisfy a listing rulesec.gov ↗
2026-05-158-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-05-068-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-03-2613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-03-258-K 8.01Other eventssec.gov ↗
2026-02-258-K 7.01Regulation FD disclosuresec.gov ↗
2026-02-258-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-02-098-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-11-258-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-11-148-K 8.01Other eventssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-11-14

Every row is a filed document, checked against its EDGAR index.